If you have been reading about Metabolite and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-11-02. Where a claim depends on a specific study, the study is described rather than over-claimed.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is not approved for human therapeutic use in any major jurisdiction. It appears on the World Anti-Doping Agency Prohibited List as a PPARδ agonist within the hormone and metabolic modulators category. Sports organizations test for it because it has been detected in athlete samples and seized products. Regulatory actions against marketed research chemical versions have occurred in several countries, though enforcement varies. Availability through unregulated channels complicates oversight.
Analytical laboratories typically identify cardarine and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is a common matrix in anti-doping testing, while blood and tissue may be used in research settings. Detection windows depend on the assay, the sample matrix, and the compound's metabolism. Because cardarine is extensively metabolized, laboratories often target specific metabolites to improve sensitivity and confirmation. Reference standards are required for reliable quantification. Method validation includes checks for selectivity, linearity, and carryover.
A persistent misconception is that cardarine is a fat-burning drug or a safe alternative to anabolic steroids. No approved therapeutic product exists, and human safety data are limited. The tumor findings in rodents remain a central concern in scientific reviews. Products sold online may contain inaccurate labels, impurities, or different compounds entirely, which complicates any assessment of effects. Independent testing of such products has reported frequent mislabeling. For these reasons, discussions in the literature emphasize risks and unknowns rather than benefits.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
GW501516 acts as a selective agonist at PPARδ, a nuclear receptor that regulates transcription of genes involved in lipid handling and energy metabolism. Activation of PPARδ in preclinical models increases fatty acid oxidation, mitochondrial biogenesis, and exercise endurance in rodents. These effects have made the compound a subject of metabolic research and also a target for sport anti-doping rules. In humans, however, controlled studies are limited, and whether similar endurance or metabolic changes occur at tolerated exposures remains an open question. The receptor’s broad tissue distribution also means downstream effects may vary by organ and condition.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
vasoconstriction temporary blockage of a hole in a damaged blood vessel by a platelet plug blood coagulation (formation of fibrin clots) Coagulation, the changing of blood from a liquid to a gel which forms the fibrin clots, is essential to hemostasis. Intact blood vessels moderate blood's tendency to form clots. The endothelial cells of intact vessels prevent blood clotting with a heparin-like molecule and thrombomodulin, and prevent platelet aggregation with nitric oxide and prostacyclin. When endothelium of a blood vessel is damaged, the endothelial cells stop secretion of coagulation and aggregation inhibitors and instead secrete von Willebrand factor, which initiates the maintenance of hemostasis after injury. These processes seal the injury or hole until tissues are healed.
== Metabolism == cADPR and ADPR are synthesized from NAD+ by the bifunctional ectoenzymes of the CD38 family (also includes the GPI-anchored CD157 and the specific, monofunctional ADP ribosyl cyclase of the mollusc Aplysia). The same enzymes are also capable of hydrolyzing cADPR to ADPR. Catalysis proceeds via a covalently bound intermediate. The hydrolysis reaction is inhibited by ATP, and cADPR may accumulate. Synthesis and degradation of cADPR by enzymes of the CD38 family involve, respectively, the formation and the hydrolysis of the N1-glycosidic bond. In 2009, the first enzyme able to hydrolyze the phosphoanhydride linkage of cADPR, i.e. the one between the two phosphate groups, was reported. SARM1 and other TIR domain-containing proteins also catalyze the formation of cADPR from NAD+.
The Cherokee Freedmen, descendants of African American slaves owned by citizens of the Cherokee Nation during the Antebellum Period, were first guaranteed Cherokee citizenship under a new treaty made in 1866 with the United States. This was in the wake of the American Civil War, when the US emancipated slaves by passing a constitutional amendment granting freedmen citizenship in the United States. After the war the US government required that the Cherokee Nation, which under pressure had briefly allied with the Confederate States of America, end slavery and grant full citizenship to Freedmen living within their nation. Those who left could become United States citizens. However, despite "the promises of the 1866 treaty, the freedmen were never fully accepted as citizens of the Cherokee Nation" during the 19th and 20th centuries. In practice, enrollment in the Cherokee Nation rolls was often strongly influenced by race. During creation of the Dawes Rolls prior to allotment of tribal communal lands to households, many Freedmen and Afro-Cherokees were listed separately from Cherokee by blood, regardless of their ancestry or culture. As a result, they did not receive land allotments and later were for a time excluded from tribal membership.
Sources: en.wikipedia.org
== Ultimate Fighting Championship (UFC) == In December 2013, the UFC began a campaign to drug test their entire roster randomly all year-round. Random testing, however, became problematic for the promotion as it began to affect revenue, as fighters who had tested positive would need to be taken out of fights, which adversely affected fight cards, and therefore pay-per-view sales. If the UFC were not able to find a replacement fighter fights would have to be cancelled. According to Steven Marrocco of MMAjunkie.com, about 31% of UFC fighters subjected to random testing since the program first started have failed due to using performance-enhancing drugs. That is approximately five failed tests for every sixteen random screenings. No fighters are exempt from these tests, no matter how big or small. Former Bantamweight champion T.J. Dillashaw tested positive for EPO following his fight with Henry Cejudo in January 2019. Jon Jones, the former Heavyweight and Light Heavyweight champion in the UFC, tested positive for banned substances in June 2016. Jones urine was found to contain Clomiphene and Letrozole which lead to a one-year suspension from the sport. Another highly decorated fighter by the name of Anderson Silva tested positive for two anabolic steroids following his bout against Nick Diaz at UFC 183. The steroids were methyltestosterone and Hydrochlorothiazide. From July 2015, the UFC has advocated to all commissions that every fighter be tested in competition for every card.
He added that "China's sovereignty, security, and development interests cannot be violated, and four red lines — the Taiwan question, democracy and human rights, development paths and systems, and development rights — cannot be challenged". Shortly after Xi arrived to the US on September 23, Treasury Secretary Bessent announced that the trade truce between the two countries, reached at the Busan Summit and was set to expire on November 10, would be extended until January 10, 2027. On September 24, Chinese defense ministry spokesperson Jiang Bin said that "it should be emphasized that the Taiwan question is the most important in China–US relations and maintaining peace and stability in the Taiwan Strait is the greatest common issue of the two countries and that "it is hoped that the US side will handle the Taiwan issue with extreme caution". Due to Trump's recent ban of several news outlets from the White House, most of Xi's state visit was not covered by the White House press pool. ABC World News Tonight placed the news of Xi's as the third item, with only photos and no video. CNN reported that the Chinese side had informally expressed its concerns to the United States that the boycott would affect the coverage of the visit. On September 24, the Trump administration returned the press credentials to the three media outlets, but still excluded CNN. The opening remarks of the summit meeting that day were not made public to the media as is customary, meaning the only publicly available video recording of the meeting was the segment broadcast by China Central Television.
== Research == Mitra's research aims to study the complex biological systems from a “theoretical engineering” perspective. He combines theoretical, computational and experimental approaches and currently understanding how brains work. Professor Mitra initiated the idea of brain-wide mesoscale circuit mapping and founded the Brain Architecture Project, including collaborations with RIKEN Brain Science Institute and Monash University. He has published over 240 research articles in peer-reviewed journals such as Nature, Science, PNAS, PRL with an H-index of 70 and holds thirty-one U.S. patents. He has also co-authored a book titled Observed Brain Dynamics published by the Oxford University Press and has written pieces for Scientific American.
Sources: en.wikipedia.org
=== Approaches of streaming media platforms === The rise in popularity of streaming content on platforms such as Netflix, Hulu, Max, and Amazon Prime Video brought easier media access for viewers, as well as decreased regulation of content for television. Since it has become easier for the public to access different media forms, including movies, TV series, or other programs worldwide, the popular streaming service Netflix demonstrates different approaches to mental illness with various portrayals. Amongst the series Netflix provided, the recent study exploring the series 13 Reasons Why found that the representations of mental-health phenomena positively influence the individual's perceptions in understanding perceived norms regarding mental health problems, such as reaching out to others for support and discussing suicide with people for prevention. 13 Reasons Why is a Netflix original with the plot surrounding a high school female, Hannah Baker, who commits suicide in the season one finale. Controversy around this TV show has arisen, especially surrounding the idea of linking Baker's suicide to a form of anger and revenge. Some argue that there is too much emphasis on how Hannah committed suicide, including the graphic visuals, and not enough focus on the true reasons behind ending her life. Others also emphasize how shows such as 13 Reasons Why simply skim over and cover only the surface of these issues and thus somehow desensitize something as important as suicide.
== Lorch Foundation == ELGA founded the Lorch Foundation in 1979, which subsequently established the School of Water Sciences. Now known as the Cranfield Water Science Institute at Cranfield University, England, it aims to support, encourage and maintain the studies of students interested in water treatment sciences. The aim of the Foundation is to "fund the furtherance of scientific research and education to the benefit of water treatment technology".
==== Smalley source ==== A laser vaporization cluster source produces ions using a combination of laser desorption ionization and supersonic expansion. The Smalley source (or Smalley cluster source) was developed by Richard Smalley at Rice University in the 1980s and was central to the discovery of fullerenes in 1985.
=== ENOUGH === Funded by: Horizon 2020 (European Commission) and European Green Deal Duration: 4 years (October 2021-September 2025) Objective: The main scope of the project is to support the EU farm-to-fork sustainable strategy by providing technical, financial, and political tools and solutions to reduce GHG emissions (by 2030) and achieve carbon neutrality (by 2050) in the food industry.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
No. Cardarine has not received approval for human therapeutic use in major jurisdictions. It remains an investigational compound.